Research & Development



  盡管從扶荔宮到雲氏的距離不算近,雲瑯,每日早出晚歸從無例外。   菜不好吃,那就吃肉喝酒……四個人喝了很多酒,排成一排在河邊撒尿的時候,李敢尿的最遠……在线亚洲视频无码天堂   百花谷現在很熱鬧。日韩av无码在线直播   “那也只有三人!”   劉徹咬咬牙齒,還是輕聲問道︰“牲畜就按照雲氏給出的章程滅殺。我現在就想知道,人呢?人怎麼樣了?”偷拍自怕亚洲在线欧美   雲瑯重重的在卓姬豐盈處拍了一巴掌道︰“別耍心眼,想要什麼就直說。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo